SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-005980
Filing Date
2020-04-07
Accepted
2020-04-07 15:00:39
Documents
12
Period of Report
2020-04-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 32609
2 ex99-1.htm EX-99.1 15691
3 ex99-2.htm EX-99.2 7053
4 ex99-1_001.jpg GRAPHIC 2190
5 ex99-2_001.jpg GRAPHIC 245857
6 ex99-2_002.jpg GRAPHIC 197439
7 ex99-2_003.jpg GRAPHIC 341741
8 ex99-2_004.jpg GRAPHIC 153281
9 ex99-2_005.jpg GRAPHIC 344392
10 ex99-2_006.jpg GRAPHIC 103543
11 ex99-2_007.jpg GRAPHIC 96436
12 ex99-2_008.jpg GRAPHIC 290070
  Complete submission text file 0001493152-20-005980.txt   2501917
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 20779494
SIC: 2834 Pharmaceutical Preparations